Australian (ASX) Stock Market Forum

Biotech stocks and medical research funding cuts

Jump to new
M

mazstar1980

Joined
12 October 2010
Posts
3
Reactions
0
Cuts to medical research funding - effect on biotech shares?

I'm wondering whether the proposed cuts to medical research in the upcoming budget will have an effect on Aussie biotech shares?

I checked PRR annual report and couldn't find evidence it received funding from grants but I'm not an expert and probably overlooked something.

I own PRR, SPL and QRX - I was hoping this would be the year for biotech but not sure how this proposal changes things, if at all.
 
How will the rumoured cuts to NHMRC funding in the federal budget affect the value of biotech stocks e.g. CSL, BTA, AVX ?

CSL says
"We draw on strategic partnerships with academic and other organisations globally to complement our in-house expertise. These collaborative partnerships support a range of programs including early-stage research and later stage development in plasma therapies, vaccines, and recombinant products."

http://corporateresponsibility.csl.com.au/?page_id=57

http://www.discoveriesneeddollars.org/news_links

I don't hold any biotech stocks currently, but I do work for an organization which would be disadvantaged by the funding cuts, should they go ahead.
 
Top